Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
carotenoid/põletik
Link salvestatakse lõikelauale
15 tulemused
Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally relates to the fields of medicinal and synthetic chemistry. More specifically, the invention relates to the synthesis and use of carotenoid analogs or derivatives.
2. Description of the Relevant Art
Recent studies have
Methods of modulating inflammation in preterm infants using carotenoids
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present disclosure relates to preterm infant formulas comprising lutein, lycopene, and beta-carotene, and the use of the preterm infant formulas to modulate inflammation, such as skin inflammation, in preterm infants.
BACKGROUND OF THE DISCLOSURE
Dietary carotenoids are lipid
Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for human nutraceuticals
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BRIEF DESCRIPTION OF THE INVENTION
This invention relates to the combination of 25-hydroxyvitamin D ("25-OH D3" and/or "25-OH D2") and antioxidants/anti-inflammatories (ascorbic acid, Vitamin E and a carotenoid) for use in human nutraceuticals, pharmaceuticals and food supplements. This combination
Combination of 25-hydroxyvitamin D and antioxidants/anti-inflammatories for bovine health
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BRIEF DESCRIPTION OF THE INVENTION
This invention relates to the combination of 25-hydroxyvitamin D ("25-OH D3" and/or "25-OH D2") and antioxidants/anti-inflammatories (ascorbic acid, Vitamin E and a carotenoid) for use in bovine feed. This combination of nutritional supplements can contribute to
Use of carotenoids for producing drugs for the treatment of dermatoses
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION
1. Field of the Invention
This application is a 371 of PCT/EP96/00381 filed on Feb. 2, 1996. The present invention relates to the use of carotenoids for producing drugs for the treatment of inflammatory disorders not caused by an infection with microorganisms or by the
Use of a reduced calorie infant formula containing nucleotides and/or carotenoids for reducing adverse health effects later in life
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE DISCLOSURE
The present disclosure is directed to the use of reduced calorie infant formulas including nucleotides and/or carotenoids for reducing long term adverse health effects, including obesity, later in life. Also disclosed are reduced calorie, reduced protein infant formulas
Antioxidant compositions for treatment of inflammation or oxidative damage
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The current invention, according to some embodiments, relates to methods of using antioxidant compositions to prevent, reduce, or eliminate the negative effects of oxidative damage or inflammation. In particular embodiments, the antioxidant compositions may be used with soft oral
Sea cucumber carotenoid lipid fraction products and methods of use
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
This patent relates to the general field of therapeutic products and methods to inhibit certain disease states related to the general medical field of human and veterinary pharmacology wherein the activation of the lipoxygenase pathways contribute to the pathological
Methods and compositions for treatment of macular and retinal disease
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION
The present invention relates to methods and compositions for treatment and prevention of disease, and in particular embodiments, disorders of the eye. In an embodiment, the present invention describes linking therapeutic compounds to xanthophyll carotenoids to enhance
Nutritional supplement compositions containing C60-fullerene-phytonutrient-triglyceride complexes for sub-cellular phytonutrient delivery
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
The present application relates generally to dietary supplements and, more particularly, to dietary supplements containing a fullerene complex that may decrease multi-system symptoms of inflammation and aging in vivo.
BACKGROUND
The "old paradigm" of disease management reflects a
Fat-based food products
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
CROSS REFERENCE TO RELATED APPLICATIONS
This application is a national phase application under 35 U.S.C. .sctn.371 that claims priority to PCT Application No. PCT/GB2012/053126 filed on Dec. 13, 2012, which claims the benefit of Great Britain Application No. 1121519.1 filed Dec. 14, 2011, both of
Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE DISCLOSURE
The present disclosure relates to human milk oligosaccharides (HMOs) for modulating inflammation in an infant, toddler, or child. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas and pediatric formulas comprising
Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE DISCLOSURE
The present disclosure relates to human milk oligosaccharides (HMOs) for modulating inflammation in an infant, toddler, or child. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas and pediatric formulas comprising
Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE DISCLOSURE
The present disclosure relates to human milk oligosaccharides (HMOs) for modulating inflammation in an infant, toddler, or child. More particularly, the present disclosure relates to human milk fortifiers, preterm and term infant formulas and pediatric formulas comprising
Pharmaceutical compositions and methods for protecting and treating sun damaged skin
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
TECHNICAL FIELD
This invention relates to pharmaceutical compositions, as well as methods, to protect skin from the armful effects of sunlight.
BACKGROUND OF THE INVENTION
The skin is the most environmentally-stressed organ in mammals, particularly in humans. Not only is the skin subjected to toxic
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
